Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2009

Comparison of Sedimentation rates of Kenalog and Triesence

R. M. Ahuja; K. N. Becker; N. J. Pathak; A. Gupta; A. Pantazis; S. Swindler; N. Becker

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):6238. doi:

ARVO Annual Meeting Abstract May 2008

Efficacy of Intravitreal Bevacizumab (Avastin) in Patients With Proliferative Diabetic Retinopathy

P. L. Tsai; K. M. Riaz; K. K. Kamat; N. J. Pathak; J. A. Rowe; R. M. Ahuja

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2736. doi:

ARVO Annual Meeting Abstract May 2008

Effect of Intravitreous Injection of Bevacizumab on Systemic Blood Pressure

N. J. Pathak; P. L. Tsai; K. K. Kamat; K. M. Riaz; M. K. Eide; A. P. Gupta; R. M. Ahuja

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5589. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Bevacizumab (Avastin) in Patients With Neovascular Glaucoma

M. K. Eide; P. L. Tsai; N. J. Pathak; K. K. Kamat; K. M. Riaz; R. M. Ahuja

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5590. doi:

ARVO Annual Meeting Abstract May 2007

Intravitreal Bevacizumab (Avastin) in Patients With Proliferative Diabetic Retinopathy

P. Tsai; K. K. Kamat; N. J. Pathak; K. Z. Danek; R. M. Ahuja

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1419. doi:

Advertisement